Drug Shortage Report for ROPIVACAINE HYDROCHLORIDE INJECTION, USP
Report ID | 235457 |
Drug Identification Number | 02439387 |
Brand name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
Common or Proper name | ROPIVACAINE HYDROCHLORIDE INJECTION, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | ROPIVACAINE HYDROCHLORIDE |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | EPIDURAL BLOCK/INFILTRATION EPIDURAL BLOCK/INFILTRATION |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 10 mL |
ATC code | N01BB |
ATC description | ANESTHETICS, LOCAL |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2024-08-26 |
Actual start date | |
Estimated end date | 2024-10-30 |
Actual end date | 2024-10-15 |
Shortage status | Resolved |
Updated date | 2024-10-17 |
Company comments | Fresenius Kabi Canada regrets to advise that due to shipping delays, we will be encountering a supply interruption on our Ropivacaine Hydrochloride Injection, USP 5 mg/mL Ampoule 10 mL effective August 26, 2024, until October 30, 2024. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2024-10-17 | French | Compare |
v6 | 2024-10-17 | English | Compare |
v5 | 2024-09-11 | French | Compare |
v4 | 2024-09-11 | English | Compare |
v3 | 2024-08-27 | English | Compare |
v2 | 2024-08-16 | French | Compare |
v1 | 2024-08-16 | English | Compare |
Showing 1 to 7 of 7